HomeINBP • OTCMKTS
add
Integrated BioPharma, Inc.
Previous close
$0.25
Year range
$0.16 - $0.30
Market cap
7.52M USD
Avg Volume
10.06K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 13.15M | 0.37% |
Operating expense | 893.00K | -7.37% |
Net income | 285.00K | 1,681.25% |
Net profit margin | 2.17 | 1,708.33% |
Earnings per share | — | — |
EBITDA | 432.00K | 232.31% |
Effective tax rate | 19.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.02M | -20.13% |
Total assets | 26.94M | 0.23% |
Total liabilities | 8.03M | -1.33% |
Total equity | 18.91M | — |
Shares outstanding | 30.10M | — |
Price to book | 0.40 | — |
Return on assets | 3.37% | — |
Return on capital | 4.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 285.00K | 1,681.25% |
Cash from operations | 1.64M | 11.77% |
Cash from investing | -345.00K | -2,056.25% |
Cash from financing | -10.00K | 0.00% |
Net change in cash | 1.29M | -10.80% |
Free cash flow | 1.44M | -13.55% |
About
Founded
1980
Headquarters
Website
Employees
141
